Senior Consultant of Hematology
National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation, Qatar
Dr Gianfranco Pittari received his International Baccalaureate from the United World Colleges and his MD degree from the University of Pavia Medical School, Italy, in 2000. He obtained his clinical hematology specialty training from the University of Parma Medical School, Italy. He subsequently received a Clinical Oncology MSc and a PhD in Immunology from the University of Paris-XI, France. He initially served as clinician at the Bone Marrow Transplantation Unit, University of Parma, and then moved to the Institut Gustave Roussy, France. In 2008, Dr Pittari moved to Memorial Sloan- Kettering Cancer Center, Immunology Program, where he worked as research fellow. Currently, he serves as Senior Consultant of Hematology at the National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation. Dr Pittari’s primary research interest is to understand how NK cells recognize and kill cancer, and discriminate normal self. The aim of his studies is to identify novel NK-based immunotherapy approaches for the treatment of leukemia and other cancers.